‘Breakthrough’ dementia drug looks to stop disease in its tracks

Medical Tech

Published on:

Source: New AtlasBy: Paul McClureDate: 12/05/2024, 3:15:00 AM
Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its breakthrough dementia treatment. ALPHA-003 is designed to preserve the integrity of vital brain cell structures and protect them against destruction caused by brain inflammation. In…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.
SubscribeSign in